B
Bruce Neal
Researcher at The George Institute for Global Health
Publications - 620
Citations - 109123
Bruce Neal is an academic researcher from The George Institute for Global Health. The author has contributed to research in topics: Population & Blood pressure. The author has an hindex of 108, co-authored 561 publications receiving 87213 citations. Previous affiliations of Bruce Neal include National Institutes of Health & University of the Western Cape.
Papers
More filters
Journal ArticleDOI
Implementing the Communication for Behavioral Impact Framework to Reduce Population Salt Consumption.
Journal ArticleDOI
Erratum. The relative and combined ability of high-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide to predict cardiovascular events and death in patients With type 2 diabetes. Diabetes Care 2014;37: 295-303
Graham S. Hillis,Paul Welsh,John Chalmers,Vlado Perkovic,Clara K Chow,Qiang Li,Min Jun,Bruce Neal,Sophia Zoungas,Neil R Poulter,Giuseppe Mancia,Bryan Williams,Naveed Sattar,Mark Woodward +13 more
Journal ArticleDOI
Socio-economic difference in purchases of ultra-processed foods in Australia: an analysis of a nationally representative household grocery purchasing panel
Daisy H. Coyle,Ling Huang,Maria Shahid,Allison Beth Gaines,Gian Luca Di Tanna,Jimmy Chun Yu Louie,Xiong-Fei Pan,Matti Marklund,Bruce Neal,Jason H Y Wu +9 more
TL;DR: In this paper , the authors examined the amount and type of ultra-processed foods purchased by Australian households in 2019 and determine whether purchases differed by socio-economic status (SES).
Journal ArticleDOI
Effects of canagliflozin on initiation of insulin and other antihyperglycaemic agents in the CANVAS Program.
David R. Matthews,Carol Wysham,Melanie J. Davies,April Slee,Maria Alba,Mary Lee,Vlado Perkovic,Kenneth W. Mahaffey,Bruce Neal,Bruce Neal,Bruce Neal +10 more
TL;DR: Compared with placebo, canagliflozin delayed the need for initiation of other AHAs and delayed time to insulin therapy, an outcome that is important to many people with diabetes.
Journal ArticleDOI
Abstract #259 Cardiovascular and Renal Outcomes with Canagliflozin in People with Type 2 Diabetes According to Baseline use of Metformin
Brendon L. Neuen,Hiddo J.L. Heerspink,Bruce Neal,David R. Matthews,Dick de Zeeuw,Kenneth W. Mahaffey,Jennifer Davidson,Meg Jardine,Sophia Zoungas,Vlado Perkovic +9 more